eHealth Beats Q2 Estimates with 27.1% Stock Jump

eHealth (NASDAQ:EHTH) reported Q2 CY2025 results beating Wall Street's revenue expectations, with sales falling 7.7% YoY to $60.78 million. The company's full-year revenue guidance of $545 million at the midpoint came in 2.5% above analysts' estimates. GAAP loss per share was $0.98, beating consensus estimates by 32.6%. Adjusted EBITDA guidance for the full year is $65 million at the midpoint, above analyst estimates of $51.68 million.

eHealth (NASDAQ:EHTH) has reported its Q2 CY2025 financial results, with the company's revenue falling by 7.7% year-over-year (YoY) to $60.78 million. Despite this decline, eHealth managed to exceed Wall Street's revenue expectations. The company's full-year revenue guidance of $545 million, at the midpoint, was 2.5% above analysts' estimates [1].

The company also reported a GAAP loss per share of $0.98, which beat consensus estimates by 32.6%. Additionally, eHealth's adjusted EBITDA guidance for the full year is $65 million at the midpoint, which is above analyst estimates of $51.68 million [1].

eHealth's Q2 results highlight the challenges faced by the healthcare sector, particularly in the digital health and telemedicine space. The company's ability to beat revenue and loss estimates, despite a decline in sales, indicates a level of operational efficiency and cost management that is reassuring for investors.

Overall, eHealth's Q2 results show a mixed performance, with a decline in revenue but strong operational metrics and guidance. Investors will be closely watching the company's ability to execute on its full-year guidance and navigate the competitive landscape in the digital health sector.

References:
[1] https://markets.financialcontent.com/stocks/?PageName=QUOTE&Ticker=EHTH